by Eamon Casey | Mar 26, 2014
Fdanews.com just published an article on the possibility of FDA and other global regulatory bodies forming a coalition called the International Coalition of Medical Regulatory Authorities (ICMRA). The goal of the ICMRA is not to develop identical standards, but to...
by Eamon Casey | Mar 26, 2014
Zachary Brennan from in-pharmatechnologist.com covered FDA’s plan to increase foreign facility inspections. FDA has made inspecting high-risk firms a top priority not just in the United States but also overseas. This is not new for FDA as they planned on visiting 750...
by Eamon Casey | Mar 26, 2014
Zachary Brennan from in-pharmatechnologist.com wrote an interesting article on the European Medicines Agency’s (EMA) move for pharmaceutical companies to produce a risk-management plan (RMP) for the public. The document will contain the known and unknown issues and...
by Eamon Casey | Mar 26, 2014
John Carroll from fiercebiotech.com just published an intriguing article on recent efforts by parents of children with severe illnesses including Duchene Muscular Dystrophy (DMD) in the wake of a recent FDA denial for compassionate use. Public relations efforts...
by Eamon Casey | Mar 21, 2014
Pearl Pathways is excited to announce our new LinkedIn Company Page. Please click this link to follow us. The Pearl Pathways LinkedIn page will contain information about the company and the services we provide. We will also post the most relevant industry and company...
